Contents
LANSOPRAZOLE OD TABLETS 30mg"TOWA" suppress acid secretion by inhibiting proton pump function.

They strongly reduce gastric acid and are often chosen as first‑line therapy for gastric ulcers and gastroesophageal reflux disease (GERD), showing good efficacy even for refractory ulcers.

OD tablets can be disintegrated on the tongue and swallowed with saliva (or taken with water).
 
Efficacy
It suppresses gastric acid secretion by inhibiting the proton‑pump enzyme in the gastric mucosa.
 
Commonly used to treat gastric and duodenal ulcers and gastroesophageal reflux disease (GERD).
 

Usage
[Gastric ulcer, duodenal ulcer, anastomotic ulcer, Zollinger–Ellison syndrome]:
Usual adult dose: 30 mg of the active ingredient once daily. Duration: up to 8 weeks for gastric and anastomotic ulcers; up to 6 weeks for duodenal ulcers.
 
[Gastroesophageal reflux disease (GERD)]:
Usual adult dose: 30 mg once daily. Duration: up to 8 weeks. For maintenance in recurrent GERD: 15 mg once daily, which may be increased to 30 mg if response is inadequate.
 
This formulation contains 30 mg of the active ingredient per tablet. 
Always follow the prescribed administration instructions.
This medication is an orally disintegrating tablet (ODT). Take it by one of the following methods:
Swallow with water or lukewarm water as you would a regular tablet.
Place on the tongue, moisten with saliva, gently crush with the tongue, and swallow with saliva. Do not take without water while lying down.
If you miss a dose, take it as soon as you remember but allow at least 8 hours before the next scheduled dose. Do not take two doses at once.
If an overdose is suspected, consult a physician or pharmacist.
Do not discontinue treatment without your physician’s instruction.

Internal capacity
30mg x 100 tablets
30mg x 500 tablets

＜Warning＞
History of allergic reactions (e.g., itching, rash) to any drugs or foods.
Presence of liver disorder.
Pregnancy or breastfeeding.
Concurrent use of other medications or products (including OTC drugs and foods)—these may increase or decrease this drug’s effects; inform your healthcare provider.

The main adverse reactions reported include rash, itching, erythema multiforme, constipation, diarrhea, dry mouth, abdominal bloating, headache, drowsiness, fever, and gynecomastia. If you experience any of these symptoms, consult your physician or pharmacist.
 
 
Rarely, the following symptoms may occur and could be early signs of the adverse reactions indicated in brackets. If you experience any of these, discontinue use and seek immediate medical attention.
 
Generalized rash, facial swelling, difficulty breathing [anaphylaxis, shock]
General fatigue, fever, shortness of breath, nosebleeds or subcutaneous bleeding, dark brown urine [pancytopenia, agranulocytosis, neutropenia, hemolytic anemia, thrombocytopenia, anemia]
Jaundice (yellowing of the skin or whites of the eyes), general fatigue, loss of appetite [severe hepatic dysfunction]
Fever, general malaise, rash or redness of the skin, eyes, or mouth [Stevens–Johnson syndrome, toxic epidermal necrolysis]
Fever, dry cough, difficulty breathing [interstitial pneumonia]

These lists are not exhaustive. If you experience any other concerning symptoms, consult your physician or pharmacist.

Ingredients 
[Active ingredient]
Per tablet:
Lansoprazole 30 mg
 
[Excipients]
D-mannitol spherical granules, L-arginine, hypromellose, D-mannitol, talc, methacrylic acid copolymer LD, sodium lauryl sulfate, polysorbate 80, ethyl acrylate/methyl methacrylate copolymer, polyoxyethylene nonylphenyl ether, triethyl citrate, macrogol 6000, glycerol fatty acid esters, citric acid monohydrate, iron(III) oxide, yellow iron oxide, hydrated silica, corn starch, aspartame (contains L-phenylalanine), flavoring, gum arabic, dextrin, magnesium stearate, light anhydrous silica, and three other ingredients.